| Composition | Vildagliptin 50mg Metformin 500mg |
|---|---|
| Dosage | TABLET |
| Packing Size | 10×15 |
| Packing | Alu-Alu |
At Avecia Healthcare, we believe that professionalism forms the foundation of trust. Our expert team is committed to providing healthcare solutions that meet global standards.
Every product we deliver is a result of thorough research, precision manufacturing, and rigorous quality checks—ensuring consistency in performance and reliability.
With a patient-first approach and a strong ethical foundation, we aim to make a lasting difference in lives by offering care that is both dependable and professionally crafted.
VILDACOP M 50/500 Tablets
VILDACOP M 50/500 is a dual-action antidiabetic medication specifically formulated to help manage type 2 diabetes effectively. Each tablet combines 50 mg of Vildagliptin and 500 mg of Metformin, offering a synergistic approach to blood sugar control.
Vildagliptin works by enhancing insulin secretion in response to meals and reducing excess glucose production in the liver. Metformin, on the other hand, improves insulin sensitivity and limits intestinal glucose absorption, helping maintain steady blood sugar levels throughout the day. This combination is particularly beneficial for patients who need better glycemic control when lifestyle changes alone are not enough.
VILDACOP M 50/500 supports long-term diabetes management, reducing the risk of diabetic complications such as nerve damage, kidney issues, and cardiovascular problems. Its easy-to-take formulation promotes better adherence, making it suitable for daily use alongside a balanced diet and regular exercise.
With consistent use and proper monitoring, VILDACOP M 50/500 helps patients achieve optimal glycemic balance, supports overall health, and enables a more active and healthy lifestyle while managing type 2 diabetes effectively.
